Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypoxia, metastatic origin and HPV16 E6/E7 expression differentially shape the radiation response in head and neck squamous cell carcinoma cell lines.

Scientific reports·2026
Same author

Synthesis and Antiproliferative Activity of Fluorinated <i>N</i>-Acetylmannosamine Analogs.

The Journal of organic chemistry·2026
Same author

Shining a light on viral detection: a comparative study of electrochemical and electrochemiluminescence techniques for human cytomegalovirus.

Analytical and bioanalytical chemistry·2026
Same author

Effects of Charged Surface on Electrochemical Sensitivity to Protein Dimerization.

Analytical chemistry·2025
Same author

LAMP-based electrochemical platform for monitoring HPV genome integration at the mRNA level associated with higher risk of cervical cancer progression.

Journal of medical virology·2024
Same author

Identification of AGR2 Gene-Specific Expression Patterns Associated with Epithelial-Mesenchymal Transition.

International journal of molecular sciences·2022

Related Experiment Video

Updated: Jul 9, 2026

Use of Interferon-&#947; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.5K

Advanced technologies towards improved HPV diagnostics.

Martin Bartosik1, Ludmila Moranova1, Nasim Izadi1

  • 1Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.

Journal of Medical Virology
|January 31, 2024
PubMed
Summary
This summary is machine-generated.

New diagnostic technologies for human papillomaviruses (HPV) offer simple, rapid, and inexpensive testing. These advancements aim to reduce cervical and head and neck cancer mortality, especially in low-income regions.

Keywords:
CRISPR-Cashuman papillomavirusisothermal amplification techniqueslab-on-a-chiplateral flow assaynanomaterials

More Related Videos

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.4K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.4K

Related Experiment Videos

Last Updated: Jul 9, 2026

Use of Interferon-&#947; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.5K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.4K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.4K

Area of Science:

  • Oncology
  • Virology
  • Biotechnology

Background:

  • Persistent high-risk human papillomavirus (HPV) infection is a primary cause of cervical cancer and a significant factor in head and neck cancers.
  • Despite advancements in screening and vaccination, HPV-related cancer incidence and mortality remain high, particularly in low-income countries.
  • Current commercial HPV tests are often costly, time-consuming, and require specialized equipment, hindering widespread use.

Purpose of the Study:

  • To review current commercial HPV diagnostic tests.
  • To describe and critically evaluate novel technologies for HPV diagnostics.
  • To suggest implementation strategies for advanced HPV testing in medical diagnostics.

Main Methods:

  • Evaluation of existing commercial HPV testing methods.
  • Description of emerging diagnostic technologies, including isothermal amplification, lateral flow assays, CRISPR-Cas systems, microfluidics, paperfluidics, and lab-on-a-chip devices.
  • Analysis of the principles, strengths, and weaknesses of these advanced technologies.

Main Results:

  • Commercial HPV tests face limitations in cost, speed, and accessibility.
  • Novel technologies show promise for rapid, inexpensive, and point-of-care HPV diagnostics.
  • These advanced methods are suitable for decentralized testing settings.

Conclusions:

  • Development of simple, rapid, and affordable HPV testing is crucial for reducing cancer burden.
  • Emerging technologies like CRISPR-Cas and microfluidics offer potential solutions to current diagnostic limitations.
  • Implementation of these novel technologies can improve cancer screening and patient monitoring globally.